Happy to recognize this stock a long time ago, and got on board over 2 years ago.
$220 million on the balance sheet
Growing revenue across international markets, in a large market segment.
Competitive advantage
Strong IP, Money well spent on R & D
Strong Management
Stable Board
Looking forward to seeing this stock pay it's first dividend in the next few years. All stars ticked, this could be potentially a Cochlear for Heart Disease.
Absolute star performer!
Add to My Watchlist
What is My Watchlist?